ClinicalTrials.gov record
Completed Phase 3 Interventional

GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS

ClinicalTrials.gov ID: NCT05266001

Public ClinicalTrials.gov record NCT05266001. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05266001
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nationwide Children's Hospital
Other
Enrollment
141 participants

Conditions and interventions

Interventions

  • GM-CSF Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
1 Day to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 13, 2022
Primary completion
Sep 9, 2025
Completion
Sep 9, 2025
Last update posted
Apr 8, 2026

2022 – 2025

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Children's Hospital of Los Angeles Los Angeles California 90027
Benioff Children's Hospital - Oakland Oakland California 64609
Children's Hospital of Orange County Orange California 92868
University of California - Davis Sacramento California 95618
Benioff Children's Hospital - Mission Bay San Francisco California 94143
Children's Hospital Colorado Aurora Colorado 80045
Children's National Medical Center Washington D.C. District of Columbia 20010
CS Mott Children's Hospital Ann Arbor Michigan 48109
Children's Hospital of Michigan Detroit Michigan 48202
Children's Hospital of Minnesota Minneapolis Minnesota 55404
University of Minnesota Minneapolis Minnesota 55455
Mercy Children's Hospital Kansas City Missouri 64108
Duke University Durham North Carolina 27705
Rainbow Babies and Children's Hospital Cleveland Ohio 44106
Nationwide Children's Hospital Columbus Ohio 43205
Pennsylvania State University Hershey Pennsylvania 17033
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15260
Medical University of South Carolina Charleston South Carolina 29425
Texas Children's Hospital Houston Texas 77030
Children's Hospital of San Antonio San Antonio Texas 78207
Primary Children's Hospital Salt Lake City Utah 84158
Virginia Commonwealth University Richmond Virginia 23298
Medical College of Wisconsin Milwaukee Wisconsin 53233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05266001, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05266001 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →